"10.1371_journal.pone.0053518","plos one","2013-01-08T00:00:00Z","David B Rosen; Kimberly H Harrington; James A Cordeiro; Ling Y Leung; Santosh Putta; Norman Lacayo; George S Laszlo; Chelsea J Gudgeon; Donna E Hogge; Rachael E Hawtin; Alessandra Cesano; Roland B Walter","Nodality Inc., South San Francisco, California, United States of America; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Division of Pediatric Hematology/Oncology, Stanford University School of Medicine, Palo Alto, California, United States of America; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Division of Hematology/Department of Medicine, University of Washington, Seattle, Washington, United States of America; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America","Conceived and designed the experiments: DBR REH AC RBW. Performed the experiments: DBR KHH JAC LL GSL CJG. Analyzed the data: DBR REH AC RBW LL JAC SP. Contributed reagents/materials/analysis tools: NL DH. Wrote the paper: DBR REH AC RBW NL DH.","DBR, LL, JAC, SP, REH, and AC are employees and stock-holders of Nodality, Inc. Based on these data, two patents entitled METHODS FOR ANALYING DRUG RESPONSE were filed by Nodality Inc. on Oct 19th, 2009 (USPTO Application No: 2/581,536) and May 1st, 2012 (USPTO Application No: 61/640794). RBW is a consultant for and receives research funding from Seattle Genetics Inc. KHH, GSL, NL, and DEH declare no potential conflicts of interest. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","David B Rosen","DBR",12,TRUE,4,6,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
